Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.
about
Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease.Comparable autoantibody serum levels against amyloid- and inflammation-associated proteins in Parkinson's disease patients and controls.Alpha-synuclein levels in blood plasma decline with healthy aging.NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases.Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer's diseaseFunction and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyondDementia With Lew Body: Impacts of Surgery.Glycation in Parkinson's disease and Alzheimer's disease.Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson’s Disease Relative to Alzheimer’s Disease and Controls.Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson's Disease Relative to Alzheimer's Disease and Controls.Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein
P2860
Q34627859-9C9024D4-16F0-43E4-8526-5EA7A14B5FDFQ35058359-C099A375-5C46-4057-9E78-E695B972B9EDQ35106166-3B379475-CD1C-4AFD-A24E-EDA1EB2960CBQ35284843-7CFB3DCF-122B-4B48-8720-E6D02DE62715Q35811161-56F61B3D-43EB-47B8-9537-E5AE548F1FC7Q35812498-2BFB17E6-FF0C-4F13-AC1D-40E99837DB09Q38363786-B440990A-251F-42D0-9F90-DE613BEA464CQ38501488-1C04CF3B-02ED-4231-83CE-DC123337F5FAQ38762228-33FE8DA1-07CB-4401-93AE-5A3C4584CC9EQ40017984-5A97B2C0-DF2F-4E24-9784-9C2DA35FA31DQ47194996-7C63B5A1-B508-4EA3-B49D-DAE6FD9B8677Q47221798-ED06BB80-B55A-4CFF-8F1B-DCB2F5ED9901Q58696119-255ABC80-B0B9-4FEA-9A7A-7AEADF7EC7C4
P2860
Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Altered serum IgG levels to α- ...... odies and Alzheimer's disease.
@ast
Altered serum IgG levels to α- ...... odies and Alzheimer's disease.
@en
Altered serum IgG levels to α- ...... odies and Alzheimer's disease.
@nl
type
label
Altered serum IgG levels to α- ...... odies and Alzheimer's disease.
@ast
Altered serum IgG levels to α- ...... odies and Alzheimer's disease.
@en
Altered serum IgG levels to α- ...... odies and Alzheimer's disease.
@nl
prefLabel
Altered serum IgG levels to α- ...... odies and Alzheimer's disease.
@ast
Altered serum IgG levels to α- ...... odies and Alzheimer's disease.
@en
Altered serum IgG levels to α- ...... odies and Alzheimer's disease.
@nl
P2093
P2860
P50
P921
P1433
P1476
Altered serum IgG levels to α- ...... bodies and Alzheimer's disease
@en
P2093
Andreas J Fallgatter
Brigitte Schreitmüller
Christoph Laske
Elke Richartz-Salzburger
Elke Stransky
Gerhard Buchkremer
Klaus Schott
Mirjam Meyer
Mona Shing
Niklas K U Koehler
P2860
P304
P356
10.1371/JOURNAL.PONE.0064649
P407
P577
2013-05-31T00:00:00Z